ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,316Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 783

$1.3M Total Retail Price of All Prescriptions

Rank: 19 out of 783

545 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 545 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 545 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 17,560 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
OMEPRAZOLE 739 656 1 6
FUROSEMIDE 626 555 2 7
HYDROCODONE-ACETAMINOPHEN 618 479 S3 3 2
LEVOTHYROXINE SODIUM 617 554 4 1
PRAVASTATIN SODIUM 611 494 5 14
AMLODIPINE BESYLATE 590 496 6 5
WARFARIN SODIUM 485 476 7 10
SERTRALINE HCL 471 358 8 22
ATORVASTATIN CALCIUM 428 376 9 11
LISINOPRIL 425 351 10 4
METOPROLOL TARTRATE 396 361 11 9
SIMVASTATIN 367 353 12 3
METFORMIN HCL 356 264 13 8
POTASSIUM CHLORIDE 342 307 14 16
PANTOPRAZOLE SODIUM 283 241 15 30
DONEPEZIL HCL 282 282 16 24
NAMENDA 275 267 17 32
METOPROLOL SUCCINATE 273 252 18 13
CITALOPRAM HBR 273 266 18 19
NOVOLOG 246 171 20 81
TRAMADOL HCL 227 205 21 20
GABAPENTIN 213 179 22 15
HYDRALAZINE HCL 202 172 23 78
CARVEDILOL 199 158 24 21
DIOVAN 189 174 25 49
ATENOLOL 188 176 26 17
POLYETHYLENE GLYCOL 3350 187 152 27 43
JANUVIA 184 174 28 73
KLOR-CON M20 176 138 29 48
CLOPIDOGREL 176 145 29 29
EXELON 164 164 31 109
DIGOXIN 160 146 32 61
TAMSULOSIN HCL 149 137 33 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 127 34 33
ADVAIR DISKUS 144 140 35 50
CIPROFLOXACIN HCL 143 136 36 62
LANTUS 143 101 36 38
ZOLPIDEM TARTRATE 139 117 38 23
ALLOPURINOL 138 117 39 31
FAMOTIDINE 133 117 40 55
OXYBUTYNIN CHLORIDE ER 132 117 41 117
RANITIDINE HCL 127 117 42 44
CYMBALTA 122 96 43 35
NEXIUM 119 92 44 28
AZITHROMYCIN 118 114 45 41
QUETIAPINE FUMARATE 118 114 45 79
PLAVIX 115 91 47 51
SPIRONOLACTONE 114 80 48 57
HYDROCHLOROTHIAZIDE 112 97 49 12
FENOFIBRATE 111 97 50 66
MELOXICAM 110 75 51 37
ESCITALOPRAM OXALATE 108 101 52 54
RISPERIDONE 106 106 53 67
LEVEMIR 104 84 54 162
GLIMEPIRIDE 104 69 54 34
CLONIDINE HCL 103 79 56 60
PREDNISONE 102 85 57 36
LOSARTAN POTASSIUM 102 76 57 18
PAROXETINE HCL 100 100 59 69
IPRATROPIUM-ALBUTEROL 99 94 60 110
ALENDRONATE SODIUM 99 99 60 25
ISOSORBIDE MONONITRATE ER 96 73 62 40
FLUTICASONE PROPIONATE 94 85 63 46
CEPHALEXIN 93 84 64 70
METHOCARBAMOL 92 63 R 65 215
LOVASTATIN 88 75 66 58
CARBIDOPA-LEVODOPA 87 87 67 88
MIRTAZAPINE 84 83 68 52
BENAZEPRIL HCL 84 70 68 85
AMLODIPINE BESYLATE-BENAZEPRIL 82 79 70 83
ROPINIROLE HCL 81 81 71 74
AMOXICILLIN 80 69 72 116
DIVALPROEX SODIUM 79 61 73 72
FENTANYL 66 43 S2 74 65
CRESTOR 66 60 74 27
DIVALPROEX SODIUM ER 64 52 76 180
DILTIAZEM HCL 64 64 76 207
NYSTATIN 61 56 78 106
CEFUROXIME 60 51 79 214
OXYBUTYNIN CHLORIDE 59 58 80 96
OLANZAPINE 58 51 81 108
LIPITOR 58 40 81 114
TRICOR 58 36 81 134
LEVETIRACETAM 57 39 84 89
BUSPIRONE HCL 55 42 85 124
CLONIDINE 54 54 86 254
SPIRIVA 54 46 86 59
CEFTRIAXONE 51 48 88 227
DIOVAN HCT 50 50 89 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.